Larimar Therapeutics Inc. buy melinda
Start price
07.04.16
/
50%
€78.15
Target price
21.07.16
€184.01
Performance (%)
-54.46%
End price
21.07.16
€35.59
Summary
This prediction ended on 21.07.16 with a price of €35.59. Massive losses of -54.46% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | -3.049% | -3.049% | 18.657% | 14.388% |
| iShares Core DAX® | -1,11 % | -0,85 % | 2,02 % | 51,34 % |
| iShares Nasdaq 100 | -4,35 % | -5,76 % | 26,25 % | 78,91 % |
| iShares Nikkei 225® | -6,79 % | -10,34 % | 53,21 % | 67,90 % |
| iShares S&P 500 | -1,79 % | -0,33 % | 21,46 % | 65,97 % |
According to melinda what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Zafgen Inc. diskutieren
(Vom Mitglied beendet)
Stopped prediction by melinda for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.94
10.12.19
10.12.19
€13.00
04.11.21
04.11.21
20.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.88
07.02.19
07.02.19
€97.42
13.02.19
13.02.19
-11.83%
13.02.19
13.02.19
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€87.46
08.03.18
08.03.18
€97.42
25.06.18
25.06.18
16.58%
25.06.18
25.06.18
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€44.92
13.05.17
13.05.17
€54.12
14.11.17
14.11.17
-12.05%
14.11.17
14.11.17
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€64.73
14.03.16
14.03.16
€81.18
04.04.16
04.04.16
26.76%
04.04.16
04.04.16
Could be worthwhile Investment >10% per year